Molindone
Encyclopedia
Molindone is a therapeutic antipsychotic
, used in the treatment of schizophrenia
. It works by blocking the effects of dopamine
in the brain, leading to diminished psychoses. It is rapidly absorbed when taken by mouth.
It is sometimes described as a typical antipsychotic
, and sometimes described as an atypical antipsychotic
.
Molindone was discontinued by its sole supplier, Endo Pharmaceuticals, on January 13, 2010.
Antipsychotic
An antipsychotic is a tranquilizing psychiatric medication primarily used to manage psychosis , particularly in schizophrenia and bipolar disorder. A first generation of antipsychotics, known as typical antipsychotics, was discovered in the 1950s...
, used in the treatment of schizophrenia
Schizophrenia
Schizophrenia is a mental disorder characterized by a disintegration of thought processes and of emotional responsiveness. It most commonly manifests itself as auditory hallucinations, paranoid or bizarre delusions, or disorganized speech and thinking, and it is accompanied by significant social...
. It works by blocking the effects of dopamine
Dopamine
Dopamine is a catecholamine neurotransmitter present in a wide variety of animals, including both vertebrates and invertebrates. In the brain, this substituted phenethylamine functions as a neurotransmitter, activating the five known types of dopamine receptors—D1, D2, D3, D4, and D5—and their...
in the brain, leading to diminished psychoses. It is rapidly absorbed when taken by mouth.
It is sometimes described as a typical antipsychotic
Typical antipsychotic
Typical antipsychotics are a class of antipsychotic drugs first developed in the 1950s and used to treat psychosis...
, and sometimes described as an atypical antipsychotic
Atypical antipsychotic
The atypical antipsychotics are a group of antipsychotic tranquilizing drugs used to treat psychiatric conditions. Some atypical antipsychotics are FDA approved for use in the treatment of schizophrenia...
.
Molindone was discontinued by its sole supplier, Endo Pharmaceuticals, on January 13, 2010.